To identify the gene products responsible for the calcium-activated chloride current in smooth muscle, reverse transcription-PCR with degenerate primers was performed on mouse intestine and other organs. A new member of the CLCA gene family was identified, mCLCA4, that is expressed preferentially in organs containing a high percentage of smooth muscle cells, including intestine, stomach, uterus, bladder, and aorta. Reverse transcription-PCR using template RNA prepared from mouse bladder and stomach smooth muscle layers dissected free of mucosa yielded mCLCA4-specific bands. In situ hybridization with an mCLCA4-specific probe confirmed prominent expression in smooth muscle of major vessels of the heart but not cardiac muscle. High expression was also detected in the gastrointestinal tract, in bronchioles, and in aortic and lung endothelial cells. Transient expression of mCLCA4 in 293T cells resulted in the appearance of a prominent calcium-activated chloride current. Whole-cell currents activated by ionomycin or methacholine were anionselective and showed minimal rectification or voltagedependent gating. Similar to endogenous currents in smooth muscle cells, methacholine-induced currents were transient, and spontaneous transient inward currents were occasionally observed at resting membrane potentials. These results link calcium-activated chloride channels in smooth muscle with a gene family whose members have been implicated in cystic fibrosis, cancer, and asthma.
Calcium-activated chloride currents have been reported in a number of cell types including exocrine gland (1-3), smooth muscle (4 -7), cardiac muscle (8, 9) , epithelium (10 -12) , and endothelium (13) . In vascular and non-vascular smooth muscle, calcium-activated chloride channels underlie one component of excitatory postsynaptic potentials (4 -6, 14) , and the local gating of Ca 2ϩ -activated chloride channels by unitary Ca 2ϩ release events results in spontaneous transient inward currents, termed STICs (15) (16) (17) . Physiological evidence suggests that activation of I Cl(Ca) 1 is an important component of rhythmic electrical activity (18, 19) and excitation/contraction coupling (20 -22) in smooth muscle. Despite the prominent role of these channels in evoked and spontaneous electrical activity of smooth muscle, the molecular identity of the underlying channel remains unknown.
A family of calcium-activated chloride channels, termed CLCA, has recently been identified at the molecular level in many epithelial and endothelial cell types (23) (24) (25) (26) (27) (28) (29) (30) . CLCA family members have been implicated in pathological states such as asthma and cancer (30 -33) , although their function in normal cell physiology is not well established. Here we report the cloning and expression of a new member of the CLCA gene family in mouse. Unlike other CLCA genes, mCLCA4 is highly expressed in smooth muscle. Transient transfection of HEK293 cells with mCLCA4 results in the expression of calcium-activated currents with anion selectivity and kinetics similar to those observed in smooth muscle. These results suggest that mCLCA4 is the gene that encodes calcium-activated chloride channels in smooth muscle and broadens the physiological and pathological relevance of the CLCA gene family.
MATERIALS AND METHODS
Identification and Isolation of mCLCA4 -RNA was prepared from mouse large intestine, kidney, and lung by grinding frozen organs with a mortar and pestle and extracting with Trizol (Invitrogen). 1 g of RNA was reverse-transcribed (Superscript, Invitrogen) using random hexamers. cDNA was subjected to PCR (93°C, 30 s; 55°C, 30 s; 72°C, 30 s; 35 cycles) with degenerate primers based on Lu-ECAM-1 amino acids 36 -45 (5Ј-ATTGCAATTAACCCCAGTGTGCCAGANGA-3Ј) and 165-174 (5Ј-GCRTAYTCRTCRAANAYNCCCCA-3Ј). PCR products were subjected to direct sequencing to rule out Taq PCR error. Distinct sequences were obtained from intestine versus kidney and lung (which were identical to mCLCA1) and were consistent across multiple RNA and cDNA preparations. The full open reading frame of mCLCA4 was obtained in two steps. Using oligo-dT-primed intestinal cDNA as a template and primers derived from the mCLCA1 sequence, a product was obtained comprising the start codon to base pair 2550. 3Ј RACE was then employed to obtain the interval from base pair 2359 to the 3Ј poly(A) tract. Primers derived from these sequences were used to amplify a 2.7-kb product containing the entire open reading frame. PCR error was minimized by using high fidelity Herculase DNA polymerase (Stratagene), by sequencing products directly before cloning, and by sequencing multiple pGEM-T clones. The final product was transferred as a SalI/SstII fragment to pIRES2 (XhoI/SstII) for expression in HEK293T cells. One 3Ј RACE product was obtained that contained an insertion at base pair 2663 (5Ј-TGGTCTGAGTACCCCCAGCACCCCT-* This work was supported by United States Army Breast Cancer Research Fund Grant DAMD17-00-1-0219 (to R. C. E.), NCI, National Institutes of Health (NIH) Public Health Service (PBS) Grant CA47668 (to B. U. P.), PHS Grant DE09692 (to K. N.), and NIH PHS Grants HL45239, HL41084, and DK58795 (to M. I. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. CCTGGTCTGAGTACCCCCAGCACCCCTCCTGGTC-3Ј), resulting in a triple repeat of the amino acid sequence LSTPSTPPG beginning at position 880. The full-length clones all lacked the insertion.
Organ and Tissue Distribution of mCLCA4 by RT-PCR-Primer pairs specific for mCLCA4 were designed based on alignment of the four known mouse CLCA genes and corresponding to the interval base pairs 1123-1443, 5Ј-catcaatgacagctcctacctagc-3Ј and 5Ј-atcaatcaggccattcacgtcttcc-3Ј. Primers were also designed to bracket at least one intron to rule out amplification of genomic DNA. Initially, a mouse multitissue cDNA array (RapidScan, Origene) was probed. To confirm and extend these results, the organs identified in the array and several others were isolated from a C57BL/6 mouse, and RNA was extracted and subjected to RT-PCR as before. Smooth muscle tissue was isolated from mouse bladder and stomach by dissecting away mucosal and serosal tissue layers under microscopic observation. 18 S ribosomal RNA was amplified as an internal control for RNA amount and reverse transcription using a primer:competitive oligomer ratio of 3:7 as described by Ambion. PCR was varied from 15 to 35 cycles to determine the range of linear amplification with added template. The profile at 25 cycles is shown. Total RNA from mouse aortic endothelial cells was a gift from Bernd Nilius (Leuven, Belgium). Lung microvascular endothelial cells were isolated from lung tumors as described (34) . In some tissues a smaller product, identified by an x in Fig. 4 , was sometimes obtained in addition to the expected band. This product was excised, inserted into pGEM-T (Promega), and determined by sequence analysis of three clones to be an artifact unrelated to mCLCA4. In addition, a Southern blot of the gel hybridized with mCLCA4 cDNA detected only the upper band.
In Situ Hybridization of Mouse Tissues-A subclone containing base pairs 2670 of the mCLCA4 open reading frame through the 3Ј-untranslated region was used for in situ hybridization analysis; this probe avoided regions with high similarity to mCLCA1 and mCLCA2. In situ hybridization studies were performed using a modification of procedures described by Wilkinson and Green (35) . Mouse tissues were fixed overnight in freshly prepared ice-cold 4% paraformaldehyde in phosphate-buffered saline. The embryos were dehydrated through ethanol into xylene and embedded in paraffin using a Tissue-Tek V.I.P. automatic processor (Miles, Mishawaka, IN). Sections (5 m) were adhered to commercially modified glass slides (Super Frost Plus, VWR, Rochester, NY), dewaxed in xylene, rehydrated through graded ethanols, and treated with proteinase K to enhance probe accessibility and with acetic anhydride to reduce nonspecific background. Singlestranded RNA probes were prepared by standard techniques with specific activities of 5 ϫ 10 9 dpm/mg. Sections were hybridized at T m Ϫ 15°C, washed at high stringency (T m Ϫ 7°C) and treated with RNase A to further diminish nonspecific adherence of probe. Autoradiography with NBT-2 emulsion (Eastman Kodak Co.) was performed for 25 days. Slides were developed with D19 (Kodak), and the tissue was counterstained with hematoxylin.
Patch Clamp Recording-The expression of I Cl(Ca) in mCLCA4-transfected and control HEK293T cells was examined by whole-cell, patch clamp recording using classical and perforated patch clamp methods as described previously (36, 37) . Briefly, HEK293T cells were transfected with green fluorescent protein-expressing pIRES2-mCLCA4 or vector alone (LipofectAMINE Plus, Invitrogen), trypsinized 24 h later, and seeded onto fibronectin-coated glass coverslips. After 18 h, cells were transferred to a temperature-controlled chamber maintained at 36°C (Brook Industries) and superfused at 1 ml/min with extracellular solution (126 mM NaCl, 1.2 mM MgCl 2 , 1.8 mM CaCl 2 , 10 mM HEPES, and 11 mM glucose; the pH was adjusted to 7.4 with NaOH. Anion shift experiments utilized the above extracellular solution in which 100 mM NaCl was replaced by an equimolar amount of sodium glutamate, shifting the theoretical chloride equilibrium potential to 24 mV (assuming zero glutamate permeability). Recording pipettes (resistance, 3-5 megaohms) were filled with 130 mM CsCl, 1.2 mM MgCl 2 , 10 mM HEPES, 10 mM glucose, 1 mM MgATP, and 0.075 mM EGTA; the pH was adjusted to 7.2 with CsOH. For perforated patch experiments, pipettes were dipped in pipette solution for 1-2 s then back-filled with pipette solution containing 200 mg/ml nystatin. After seal formation and establishment of the whole cell recording configuration, cells were voltage-clamped at Ϫ60 mV (Axopatch 200 B, Axon Instruments). Records were filtered at 500 Hz and sampled at 1 kHz. Current reversal potentials were measured either by step or ramp (Ϫ60 to 40 mV applied every 30 s) protocols. Cells were exposed to calcium-mobilizing agents (ionomycin or methacholine) by means of a puffer pipette connected to a controlled solenoid (Picospritzer, General Valve Corp.). A microscope equipped with an ultraviolet source was used to select green fluorescent protein-positive cells for recording.
RESULTS
Identification and Cloning of a New CLCA Family Member-To identify the CLCA isoform present in mouse smooth muscle, RT-PCR was performed with degenerate primers on template RNA extracted from an organ rich in smooth muscle, the large intestine. Degenerate primers for RT-PCR were designed based on published CLCA sequences to amplify any CLCA cDNA including mCLCA1, mCLCA2, and mCLCA3. Thus, RNA extracted from established sites of mCLCA1 expression, lung and kidney, could serve as positive controls for amplification of CLCA mRNA. RT-PCR of intestinal RNA produced a much stronger band than either lung or kidney (Fig. 1) . Direct sequencing of the amplification products revealed only the mCLCA1 sequence in lung and kidney but a new and distinct sequence in intestine, which we have designated mCLCA4. The electropherogram showed no sign of mCLCA3, previously reported in intestinal goblet cells, indicating that mCLCA4 is the predominant CLCA family member in large intestine (data not shown). The full 2.7-kb, 909-amino acid open reading frame of mCLCA4 was obtained using primers derived from the mCLCA1 sequence and 3Ј RACE (Fig. 2) . Comparison of the mCLCA4 amino acid and DNA sequences with those of the other mouse CLCA family members revealed an abrupt divergence at amino acid 873 resulting from a frameshift mutation ( Fig. 2 ; GenBank TM accession number AY00827). mCLCA4 retains 79% identity with mCLCA1 and mCLCA2 but only 45% with mCLCA3. All of the general features found in other CLCA family members, such as the symmetrical cysteine cluster, processing sites, and glycosylation sites are conserved in mCLCA4 (Fig. 2) . Construction of a phylogenetic tree of known CLCA proteins places mCLCA4 on Branch A, whose members all bear the sequence RARSPT (corresponding to amino acids 592-597 of mCLCA4), containing two adjacent sites for phosphorylation by calcium/calmodulin kinase II and protein kinase C as well as a site for protein kinase A (Fig. 3) . Members on branches B and C lack this sequence (note that the genetic nomenclature is based on order of discovery; thus, mCLCA4 is not the ortholog of hCLCA4).
Tissue Distribution of mCLCA4 Expression-In preliminary experiments, to identify tissues in which mCLCA4 was expressed, a multi-organ mouse cDNA array (RapidScan, Origene) was probed by RT-PCR with primers that recognized mCLCA4 but not other mouse CLCA family members. Expression was detected in the gastrointestinal tract, uterus, and heart (data not shown). To confirm and extend these results, these and other organs were dissected and analyzed from a C57BL/6 mouse. Expression was highest in large and small intestine and was also significant in stomach and esophagus but just detectable in salivary gland ( Fig. 4A; lower band x is an  artifact) . Outside the gastrointestinal tract, strong expression was detected in uterus and lung, and lower expression was detected in aorta, heart, and skeletal muscle, whereas none was detectable in kidney or pancreas (Fig. 4A) . To determine whether mCLCA4 expression in mixed organs was associated with expression in smooth muscle, two mouse organs were chosen in which the smooth muscle layer could be dissected free of overlying tissue layers. The tunica muscularis was dissected from the mouse bladder and stomach for RNA preparation and RT-PCR. As shown in Fig. 4B , isolated smooth muscle from both tissues was strongly positive for mCLCA4 expression, with stomach more prominent.
Cellular Expression of mCLCA4 -To determine the sites of expression at higher resolution, we probed tissue sections by in situ hybridization with an mCLCA4-specific 33 P-labeled cRNA probe derived from the 3Ј-untranslated region. The best evidence for expression in smooth muscle was observed in vessels associated with the heart. A very strong signal was observed in the walls of the aorta with a much lower signal in adjoining cardiac muscle and little signal above background in the endothelium of the aortic valve (Fig. 5, a and e) . The pulmonary vein (Fig. 5, b and f) and its branches were also intensely labeled, whereas the coronary artery was less so (Fig. 5, c and g ). Connective and adipose tissues were consistently negative. The atrioventricular bundle, consisting of muscle cells modified to function as nerve fibers, was also positive (not shown). In lung, the signal was concentrated around bronchioles and blood vessels (Fig. 6, a-d) . Surprisingly, in the gastrointestinal tract mCLCA4 expression was more strongly associated with the mucosa than with underlying smooth muscle (Fig. 6, e-h) . In small intestine for example, label was concentrated in villi, whereas smooth muscle layers were more weakly labeled. In contrast to mCLCA1 and mCLCA3, mCLCA4 signal was not confined to deep crypt or goblet cells.
The aortic wall in mouse consists mostly of smooth muscle with only a single layer of endothelial cells lining the vessel interior. Because endothelial cells are difficult to detect by in situ hybridization, we obtained endothelial cells that had been isolated from aorta or lung microvasculature and analyzed them by RT-PCR. Endothelial cells from either source had high levels of mCLCA4 expression (Fig. 4C) .
mCLCA4 Mediates a Calcium-activated Chloride Current-To determine whether mCLCA4 encodes a functional chloride channel, the cDNA was inserted into a vector bearing a green fluorescent protein marker and transfected into HEK293T cells, and whole cell currents of fluorescent cells were measured. Recordings were made in extracellular solution containing Cs ϩ substituted for Na ϩ to block any calciumactivated potassium currents. Under these conditions, mCLCA4-transfected HEK cells, but not vector-transfected cells, exhibited a prominent inward current when exposed to ionomycin (Fig. 7A) . 16 of 23 cells exposed to ionomycin displayed prominent inward currents, whereas no current was observed in 6 cells transfected with vector alone. The evoked currents were transient in nature even when evoked after exposure to ionomycin, which results in a sustained increase in [Ca 2ϩ ] i ; inactivation of the smooth muscle calcium-activated chloride channel that is independent of Ca 2ϩ has been reported (38) . Methacholine was also used to stimulate calcium release via endogenous muscarinic receptors. As shown in Fig. 7B , methacholine activated a transient current of similar time course and smaller magnitude than ionomycin (Fig. 7B) . A A longitudinal section of the heart was hybridized with a 33 P-labeled mCLCA4 probe, exposed to photo-emulsion, and examined by UV (ultraviolet autofluorescence, a-c) or dark-field optics (d-h). Significant hybridization was observed in aorta (a and e), right pulmonary vein (b and f), coronary artery (c and g), and all other vessels in the section (d) with the antisense RNA probe, whereas the sense control produced no hybridization above background (h). Specimens were photographed using a 10ϫ (a and e), 20ϫ (b, c,  f, and g) or 5ϫ (d and h) objective. aw, aortic wall; av, aortic valve; cm, cardiac muscle; ct, connective tissue.
second prominent feature of expression of mCLCA4 was the appearance of spontaneous transient inward currents (STICs) similar to those observed in smooth muscle cells from several tissues (17, 39) . Spontaneous currents were observed in 10 of 29 cells transfected with mCLCA4 (Fig. 7C) , whereas in 21 cells transfected with a green fluorescent protein plasmid lacking mCLCA4 no spontaneous methacholine-activated chloride currents were observed.
To obtain the current-voltage relationship of the calciumactivated inward current, a step depolarization experiment was performed. As shown in Fig. 8A , the I-V relationship was linear over the voltage range from Ϫ60 to 40 mV, indicating little voltage dependence of gating or intrinsic rectification of mCLCA4 over this voltage range, similar to findings for mCLCA1 (25) and consistent with the electrophysiological behavior of these channels in smooth muscle (20) . The current was shown to be chloride-selective by substitution of extracellular Cl Ϫ ions with glutamate ions (Fig. 8B ). In these experiments, the current was activated by exposure of cells to ionomycin in the presence of normal extracellular solution or the same solution in which 100 mM NaCl was replaced by 100 mM sodium glutamate; glutamate ions have a permeability ratio in calcium-activated chloride channels of approximately 0.05 relative to Cl Ϫ ions (1, 40) . In the presence of glutamate ions substituted for chloride ions, the reversal potential of the calcium-activated inward current shifted from 0 to 18.2 Ϯ 3.6 mV (n ϭ 6; Fig. 8B ), which was quite close to the theoretical E Cl (24 mV, assuming zero glutamate permeability) and confirmed the anion selectivity of the channel.
DISCUSSION
The CLCA gene family comprises an expanding group of calcium-activated chloride channels. To date, the expression of known CLCA genes has been largely restricted to epithelial and endothelial tissue, from which they were first cloned (23, 24) . Despite early reports of prominent calcium-activated chloride currents in Xenopus oocytes (41) , neurons (42, 43) , secretory gland (1), and smooth muscle cells (4) , in large measure the genes responsible for these currents have not been clearly identified, and the extent to which they represent variants of the described CLCA or ClC (44) gene families has been uncertain. The identification of a CLCA gene with prominent expression patterns in smooth muscle significantly expands the potential importance of this gene family.
In general, calcium-activated chloride channels in various mammalian tissues are similar in single-channel conductance, anion selectivity, and drug sensitivity (for review, see Ref. 45 ). These and other shared properties led to the proposal that all calcium-activated chloride channels in mammalian tissues may be mediated by a family of closely related proteins (20) . Although the CLCA family is deeply divergent at the amino acid level, all share several features. The CLCA precursor is about 900 amino acids long and contains two proteolytic cleavage sites. The first cleavage removes the amino-terminal signal sequence, resulting in a long extracellular amino-terminal tail. The second cleavage event removes the carboxyl-terminal ϳ200 amino acids, yielding products of 90 and 30 -40 kDa, both closely associated with the plasma membrane (24 -27) . Another signatory feature is a symmetrical cluster of cysteines, CX 12 CX 4 CX 4 CX 12 C, around amino acid 200. The structure and stoichiometry of the channel remain to be established.
We report the cloning and functional expression of a novel member of the CLCA family, termed mCLCA4. The gene product is strongly related to mCLCA1 and mCLCA2 and shares the potential phosphorylation sites for calcium/calmodulin kinase II, consistent with regulation by intracellular calcium. A, during exposure of mCLCA4-transfected HEK293T cells to ionomycin, step depolarization was imposed to obtain the current/voltage relationship. The magnitudes of the currents at the end of the step are plotted below. Note that the current reversal potential is ϳ0 mV in symmetrical chloride solution. B, the shift in current reversal potential is shown for a cell recorded in symmetrical chloride solution and in solution in which chloride was replaced by glutamate in the extracellular solution. As shown, the current reversal potential was shifted to close to the theoretical chloride equilibrium potential (24 mV).
RT-PCR and in situ hybridization analysis indicates substantial expression of mCLCA4 in smooth muscle and certain epithelial and endothelial tissues. Expression in smooth muscle was never observed for mCLCA1, mCLCA2, or mCLCA3 (46, 47, 31) and suggests that mCLCA4 may be associated with chloride currents recorded in this tissue. Expression studies with mCLCA4 were consistent with this notion, and transfection of HEK293T cells with mCLCA4 resulted in the expression of a prominent calcium-activated chloride current. The currentvoltage relationship measured in voltage steps during exposure to ionomycin was consistent with a very weakly voltage-dependent channel, similar to measurements of calcium-activated chloride currents in smooth muscle (20) and other tissues (1, 41) . Similarly, despite sustained elevations of [Ca 2ϩ ] i obtained with ionomycin, the activated current decayed with kinetics generally similar to that observed in smooth muscle (38) . The appearance of spontaneous, transient calcium-activated currents, a prominent feature of smooth muscle chloride currents (17) , also suggests a marked functional similarity between mCLCA4 and the smooth muscle channel.
In summary, we report the sequence and functional expression of a novel calcium-activated chloride channel with distinct tissue expression. Although the definitive determination of the extent to which this channel underlies specific postsynaptic currents in smooth muscle or secretory cells will require careful comparison of biophysical properties of heterologously expressed mCLCA4 with currents recorded in native cells and gene targeting experiments, our data identify mCLCA4 as a likely candidate for calcium-activated chloride currents in smooth muscle.
